|  Help  |  About  |  Contact Us

Publication : Identification of Pre-symptomatic Gene Signatures That Predict Resilience to Cognitive Decline in the Genetically Diverse AD-BXD Model.

First Author  Neuner SM Year  2019
Journal  Front Genet Volume  10
Pages  35 PubMed ID  30787942
Mgi Jnum  J:275861 Mgi Id  MGI:6307137
Doi  10.3389/fgene.2019.00035 Citation  Neuner SM, et al. (2019) Identification of Pre-symptomatic Gene Signatures That Predict Resilience to Cognitive Decline in the Genetically Diverse AD-BXD Model. Front Genet 10:35
abstractText  Across the population, individuals exhibit a wide variation of susceptibility or resilience to developing Alzheimer's disease (AD). Identifying specific factors that promote resilience would provide insight into disease mechanisms and nominate potential targets for therapeutic intervention. Here, we use transcriptome profiling to identify gene networks present in the pre-symptomatic AD mouse brain relating to neuroinflammation, brain vasculature, extracellular matrix organization, and synaptic signaling that predict cognitive performance at an advanced age. We highlight putative drivers of these observed relationships, including Itgb2, Fcgr2b, Slc6a14, and Gper1, which represent prime targets through which to promote resilience prior to overt symptom onset. In addition, we identify a genomic region on chromosome 2 containing variants that directly modulate resilience network expression. Overall, work here highlights new potential drivers of resilience to AD and contributes significantly to our understanding of early, potentially causal, disease mechanisms.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

49 Bio Entities

0 Expression